Chapter
2 - Reactive and Inflammatory Conditions of the Breast
GRANULOMATOUS LOBULAR MASTITIS
SCLEROSING LYMPHOCYTIC LOBULITIS
3 - Infections of the Breast
LACTATING BREAST INFECTION
NONLACTATING BREAST INFECTION
ZUSKA’S (SMOLDERING) BREAST DISEASE
MISCELLANEOUS BREAST INFECTIONS
4 - Epidemiology of Breast Cancer
RISK FACTORS FOR BREAST CANCER
5 - Patient Safety in Breast Pathology
CHANGING ROLE OF PATHOLOGISTS IN BREAST CANCER DIAGNOSIS AND MANAGEMENT
CURRENT CHALLENGES IN THE PRACTICE OF BREAST PATHOLOGY
SUGGESTIONS TO MINIMIZE ERRORS IN BREAST PATHOLOGY
IMPLEMENTATION OF PATIENT SAFETY–CENTERED BREAST PATHOLOGY IN PRACTICE
6 - Gross Examination of Breast Specimens
PERCUTANEOUS CORE NEEDLE BIOPSIES
WIRE-GUIDED EXCISIONS/LUMPECTOMIES
PITFALLS IN EVALUATING EXCISIONS AND MASTECTOMIES
EXAMINATION OF BREAST SPECIMENS AFTER NEOADJUVANT THERAPY
CHALLENGES IN EVALUATING SPECIMENS AFTER NEOADJUVANT THERAPY
EXAMINATION OF BREAST PROSTHESES (IMPLANTS)
INTRAOPERATIVE EXAMINATION OF BREAST SPECIMENS
STANDARD OPERATING PROCEDURES FOR GROSS EXAMINATION OF BREAST SPECIMENS
7 - Sentinel Lymph Node Biopsy
CLINICAL PARAMETERS AND FEASIBILITY ISSUES
PREDICTORS OF SENTINEL NODE METASTASIS
AMERICAN JOINT COMMISSION ON CANCER STAGING OF SENTINEL LYMPH NODES
CONTROVERSIAL ISSUES WITH REGARD TO HISTOLOGIC ASSESSMENT
PREDICTORS OF NONSENTINEL LYMPH NODE INVOLVEMENT
8 - Breast Imaging Modalities for Pathologists
MAGNETIC RESONANCE IMAGING
BREAST-SPECIFIC GAMMA IMAGING
POSITRON-EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY
SENTINEL LYMPH NODE IMAGING
METHODS FOR OBTAINING, MARKING, AND LOCALIZING A TISSUE SAMPLE
NEW METHODS ON THE HORIZON
9 - Predictive and Prognostic Marker Testing in Breast Pathology: Immunophenotypic Subclasses of Disease
HORMONE RECEPTORS IN BREAST CARCINOMA
HER2 (ERBB2) ONCOGENE IN BREAST CARCINOMA
OTHER RELEVANT PROGNOSTIC/PREDICTIVE MARKERS
10 - Molecular-based Testing in Breast Disease for Therapeutic Decisions
11 - Diagnostic Immunohistology of the Breast
ASSESSMENT OF STROMAL INVASION
IMMUNOHISTOCHEMISTRY OF PAPILLARY LESIONS
PROLIFERATIVE DUCTAL EPITHELIAL LESIONS AND IN SITU CARCINOMAS
TUMOR TYPE IDENTIFICATION BY IMMUNOHISTOCHEMISTRY
PAGET’S DISEASE OF THE BREAST
DETECTION OF LYMPHATIC SPACE INVASION
SENTINEL LYMPH NODE EXAMINATION
SYSTEMIC METASTASIS OF BREAST CARCINOMA
12 - Fibroepithelial Lesions
13 - Papilloma and Papillary Lesions
14 - Adenosis and Microglandular Adenosis
15 - Nipple Adenoma (Florid Papillomatosis of the Nipple)
17 - Myoepithelial Lesions of the Breast
18 - Fibrocystic Change and Usual Epithelial Hyperplasia of Ductal Type
19 - Columnar Cell Alterations, Flat Epithelial Atypia, and Atypical Ductal Epithelial Hyperplasia
COLUMNAR CELL ALTERATIONS AND FLAT EPITHELIAL ATYPIA
IMMUNOHISTOLOGY OF COLUMNAR CELL–RELATED LESIONS
RELATIONSHIPS AMONG FLAT EPITHELIAL ATYPIA, LOBULAR NEOPLASIA, ATYPICAL DUCTAL EPITHELIAL HYPERPLASIA, LOW-GRADE DUCTAL CARCINOM...
20 - Molecular Classification of Breast Carcinoma
INTRINSIC GENE SET–BASED MOLECULAR CLASSIFICATION
MOLECULAR ANALYSES OF SPECIAL SUBTYPE CARCINOMAS
MOLECULAR PROFILING OF METASTATIC DISEASE
OTHER MULTIGENE PREDICTION ASSAYS
IMMUNOHISTOCHEMICAL SURROGATES TO MOLECULAR CLASSES
21 - Lobular Neoplasia and Invasive Lobular Carcinoma
LOBULAR CARCINOMA IN SITU AND ATYPICAL LOBULAR HYPERPLASIA
INVASIVE LOBULAR CARCINOMA
MOLECULAR PATHOLOGY OF LOBULAR CARCINOMA
22 - Ductal Carcinoma In Situ
23 - Invasive Ductal Carcinoma of No Special Type and Histologic Grade
INVASIVE CARCINOMA OF NO SPECIAL TYPE (DUCTAL NST)
24 - Triple-Negative and Basal-like Carcinoma
BREAST CANCER MOLECULAR TAXONOMY
25 - Metaplastic Breast Carcinoma
26 - Apocrine Carcinoma of the Breast
27 - Paget’s Disease of the Breast
28 - Pathology of Neoadjuvant Therapeutic Response of Breast Carcinoma
PREDICTORS OF THERAPEUTIC RESPONSE
EVALUATION OF THERAPEUTIC RESPONSE
POST-TREATMENT PROGNOSTIC AND PREDICTIVE FACTORS
SYSTEMS FOR EVALUATING DEGREE OF RESPONSE
REPORTING OF POST-TREATMENT SPECIMEN
29 - Special Types of Breast Carcinoma: Tubular Carcinoma, Mucinous Carcinoma, Cribriform Carcinoma, Invasive Micropapillary Carcinoma, and Medullary Carcinoma
INVASIVE CRIBRIFORM CARCINOMA
INVASIVE MICROPAPILLARY CARCINOMA
30 - Rare Breast Carcinomas: Adenoid Cystic Carcinoma, Neuroendocrine Carcinoma, Secretory Carcinoma, Carcinoma with Osteoclast-like Giant Cells, Lipid-Rich Carcinoma, and Glycogen-Rich Clear Cell Carcinoma
CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS
GLYCOGEN-RICH CLEAR CELL CARCINOMA
31 - Mesenchymal Neoplasms of the Breast
HAMARTOMA (ADENOLIPOMA, CHONDROLIPOMA, AND MYOID HAMARTOMA)
MALIGNANT VASCULAR TUMORS
MYOFIBROBLASTIC PROLIFERATIONS
MISCELLANEOUS BENIGN MESENCHYMAL TUMORS
32 - Neoplasia of the Male Breast
BENIGN PROLIFERATIVE LESIONS
CARCINOMA OF THE MALE BREAST
33 - Breast Tumors in Children and Adolescents
PAPILLARY DUCT HYPERPLASIA (PAPILLOMA, PAPILLOMATOSIS)
ATYPICAL DUCT HYPERPLASIA
34 - Tumors of the Mammary Skin
BENIGN SKIN TUMORS OF THE SURFACE EPITHELIUM
SURFACE CARCINOMAS OF THE MAMMARY SKIN
NONVASCULAR CUTANEOUS MESENCHYMAL LESIONS OF THE MAMMARY SKIN
BENIGN CUTANEOUS VASCULAR AND PERIVASCULAR TUMORS OF THE BREAST
MELANOCYTIC LESIONS OF THE MAMMARY SKIN
HEMATOPOIETIC TUMORS OF THE MAMMARY SKIN
METASTATIC TUMORS OF THE MAMMARY SKIN
35 - Hematopoietic Tumors of the Breast
OTHER NON-HODGKIN’S LYMPHOMAS
MYELOID NEOPLASMS AND EXTRAMEDULLARY HEMATOPOIESIS
HISTIOCYTIC/DENDRITIC CELL PROLIFERATIONS
36 - Metastatic Tumors in the Breast